Lonza Group (OTCMKTS:LZAGY) Sees Strong Trading Volume – Here’s What Happened

Shares of Lonza Group Ag (OTCMKTS:LZAGY) saw unusually-high trading volume on Friday . Approximately 106,022 shares were traded during trading, an increase of 31% from the previous session’s volume of 80,695 shares.The stock last traded at $66.9675 and had previously closed at $66.26.

Wall Street Analyst Weigh In

Separately, Zacks Research upgraded Lonza Group from a “strong sell” rating to a “hold” rating in a research note on Wednesday, April 8th. One analyst has rated the stock with a Buy rating and one has issued a Hold rating to the company’s stock. According to MarketBeat, Lonza Group currently has an average rating of “Moderate Buy”.

Lonza Group Price Performance

The stock has a fifty day simple moving average of $65.39 and a 200-day simple moving average of $65.61. The company has a debt-to-equity ratio of 0.42, a quick ratio of 1.77 and a current ratio of 2.24.

About Lonza Group

Lonza Group is a Swiss multinational life sciences company that provides products and services to the pharmaceutical, biotech and specialty ingredients markets. Headquartered in Switzerland, the company operates globally with manufacturing and research facilities across Europe, North America and Asia, serving customers involved in drug discovery, development and commercial production. Lonza’s client base ranges from large pharmaceutical firms to emerging biotech companies and manufacturers of consumer health and specialty chemical products.

The company’s core activities center on contract development and manufacturing (CDMO) for small molecules and biologics, including process development, clinical and commercial-scale manufacturing, and fill–finish services.